Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRX and other ETFs, options, and stocks.
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas.
52 Week high
52 Week low
-$0.31 per share
-$0.28 per share